AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


Injective (INJ) has held above the $6 level amid cautious optimism among analysts, who are closely monitoring the $6.30 resistance zone as a critical juncture for the token's near-term trajectory.
a mixed outlook, with the 14-day RSI at 52.679 signaling a neutral stance, while an even split of six buy and six sell signals. The price's ability to break above $6.30 could validate bullish momentum, but bearish pressure remains evident through key metrics. the EMA 50 and EMA 200, reinforcing a downtrend that has persisted since mid-October.
Investor sentiment remains divided. Some analysts argue that INJ's current valuation may not yet justify aggressive buying,
and key resistance hurdles. Others see the $5.00 support level as a potential entry point if a technical correction occurs without fundamental deterioration. For now, the market is in a holding pattern, with the $6.30 threshold serving as a pivotal test of buyer resolve.Quickly understand the history and background of various well-known coins

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025

Dec.02 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet